Business

Fundamental Research Corp Initiates Coverage on CanaQuest (CANQF) with Buy Rating and US$0.78 Fair Value Estimate

Fundamental Research Corp Initiates Coverage on CanaQuest (CANQF) with Buy Rating and US$0.78 Fair Value Estimate.

articleCanaquest Medical CorporationMarch 23, 20213/company/canaquest-medical-corp/news/fundamental-research-corp-initiates-coverage-on-canaquest-canqf-with-buy-rating-and-usdollar078-fair-value-estimate
Fundamental Research Corp Initiates Coverage on CanaQuest (CANQF) with Buy Rating and US$0.78 Fair Value Estimate

About this update from Canaquest Medical Corporation

[{"type":"text","content":"CanaQuest Targeting Same Mental Health Space Where GW Pharma was Acquired for US$7.2BTORONTO, ON / ACCESSWIRE / March 23, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced that Fundamental Research Corp ("FRC"), one of the world's largest independent research houses, has launched coverage on CanaQuest with a BUY Rating. Its full report is available here: https://canaquest.com/wp-content/uploads/2021/03/CanaQuest-Research-Report-by-FRC-March-2021.pdfFRC has a 17-year track record of covering 550+ companies since inception. An excerpt from FRC's report is included below…"In conclusion, we believe the company's formulations have potential to generate demand based on their differentiating features. Even though we are not in position to verify the company's claims regarding higher efficacy levels, we believe recognition by academic journals is highly encouraging. The company's prospects are heavily dependent on management's ability to raise capital and obtain approvals. We believe the current financing (if completed), and near-term sales of non-Rx products will be the key catalysts this year. We are initiating coverage with a BUY rating, and a fair value estimate to US$0.78."About Fundamental Research Corp:Fundamental Research Corp is one of the largest independent research houses in the world, with a 17-year track record of covering 550+ companies. As of March 12, 2021, FRC's top picks were up 76.4% on average since initiation of coverage. The Company is a premier research firm that has ranked in the Top Ten in independent third-party evaluations of its research.For more information on Fundamental Research Corp, visit https://www.researchfrc.com/About CanaQuest Medical Corp:CanaQuest Medical Corp is a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade). The Company is the industry partner for research and product development with Dr. Steven Laviolette, a professor and neuroscientist, who has 20 years of research experience in the field of mental health and cannabinoids and ...

More updates from Canaquest Medical Corporation